Market Insights Health Pharmacies OTC Products

Hand Sanitizer (Pharmacies) - United States

United States

Revenue in the Hand Sanitizer market is projected to reach €354.00m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.12%, resulting in a market volume of €433.10m by 2029.
In global comparison, most revenue will be generated in China (€357.20m in 2024).
In relation to total population figures, per person revenues of €1.04 are generated in 2024.

Key regions: Japan, United States, Europe, United Kingdom, Canada

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Hand Sanitizer (Pharmacies) market in United States is experiencing significant growth due to changing customer preferences and increasing awareness about hygiene and health.

Customer preferences: Customers in United States are increasingly prioritizing hygiene and health, leading to a surge in demand for hand sanitizers. The COVID-19 pandemic has played a crucial role in shaping these preferences, as people have become more cautious about preventing the spread of germs and viruses. Hand sanitizers have become an essential item for individuals to carry with them at all times, resulting in a higher demand for these products in pharmacies.

Trends in the market: One of the key trends in the Hand Sanitizer (Pharmacies) market in United States is the shift towards natural and organic hand sanitizers. With growing concerns about the chemicals used in conventional hand sanitizers, customers are seeking healthier alternatives. Natural and organic hand sanitizers, made with ingredients such as aloe vera and essential oils, are gaining popularity as they are considered safer and gentler on the skin. Pharmacies are catering to this trend by offering a wider range of natural and organic hand sanitizers to meet the evolving customer preferences. Another trend in the market is the increasing availability of hand sanitizers in various forms and sizes. Pharmacies are offering hand sanitizers in different packaging options such as bottles, sprays, and wipes, providing customers with more choices. Additionally, hand sanitizers are now available in travel-sized packs, making it convenient for individuals to carry them while on the go. This trend is driven by the need for portability and ease of use, further fueling the growth of the Hand Sanitizer (Pharmacies) market in United States.

Local special circumstances: The Hand Sanitizer (Pharmacies) market in United States is influenced by the country's healthcare system and regulations. The Food and Drug Administration (FDA) regulates hand sanitizers, ensuring that they meet safety and efficacy standards. This regulatory framework creates a level playing field for manufacturers and instills confidence in customers regarding the quality of hand sanitizers available in pharmacies. The stringent regulations also help in preventing the proliferation of substandard or counterfeit products, maintaining the reputation of the market.

Underlying macroeconomic factors: The Hand Sanitizer (Pharmacies) market in United States is also influenced by macroeconomic factors such as population growth, disposable income, and healthcare expenditure. The country has a large and growing population, which provides a significant customer base for the market. Moreover, the increasing disposable income of individuals allows them to spend more on health and hygiene products, including hand sanitizers. Additionally, the rising healthcare expenditure in United States indicates a greater focus on preventive healthcare, driving the demand for hand sanitizers in pharmacies. In conclusion, the Hand Sanitizer (Pharmacies) market in United States is witnessing growth due to changing customer preferences towards hygiene and health. The demand for natural and organic hand sanitizers, as well as the availability of hand sanitizers in different forms and sizes, are key trends in the market. The country's healthcare system and regulations, along with underlying macroeconomic factors, further contribute to the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.